Shirley Chen

Shirley Chen leads the planning and execution of biomedical product launches—including innovative drugs and therapeutics as well as diagnostic technologies—across several program and disease areas in the foundation’s Global Health Division. Product launches for such complex health interventions in low- and middle-income countries require the use of novel approaches and channels to enable broad and sustainable uptake.

Before joining the foundation in 2019, Shirley served in commercial and operational leadership roles spanning the U.S., Asia, and Europe in the biopharmaceutical industry at Pfizer. She was most recently based in the UK as the regional commercial lead for the hemophilia portfolio in the rare diseases business unit for Europe and Asia, following a regional leadership role based in Hong Kong to build the rare diseases commercial organization and business in Southeast Asia and India. Shirley started her career as an R&D chemist in the specialty chemicals industry before transitioning to marketing and business roles and moving to the biopharmaceutical industry.

Shirley has a B.S. in chemistry from Georgia Tech and an MBA from the New York University Stern School of Business.